Percutaneous Tricuspid Valve Repair

Antonio Mangieri; Alessandro Sticchi; Aisha Gohar; Damiano Regazzoli; Fabio Fazzari; Daniela Pini; Marta Pellegrino; Beniamino Pagliaro; Ferdinando Loiacono; Mauro Chiarito; Bernhard Reimers; Fabien Praz; Azeem Latib; Antonio Colombo

doi:10.31083/J.RCM2307220

Percutaneous Tricuspid Valve Repair

Antonio Mangieri, Alessandro Sticchi, Aisha Gohar, Damiano Regazzoli, Fabio Fazzari, Daniela Pini, Marta Pellegrino, Beniamino Pagliaro, Ferdinando Loiacono, Mauro Chiarito, Bernhard Reimers, Fabien Praz, Azeem Latib, Antonio Colombo

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternative solution for such patients since they represent a valid alternative to open heart surgery without the significant risks carried by surgery. A number of percutaneous devices are currently under clinical development. This review will discuss about the latest development in the field of percutaneous tricuspid valve repair with possible future developments.

Original language	English (US)
Article number	220
Journal	Reviews in Cardiovascular Medicine
Volume	23
Issue number	7
DOIs	https://doi.org/10.31083/J.RCM2307220
State	Published - 2022
Externally published	Yes

Keywords

heart failure
percutaneous tricuspid valve repair
right heart failure
right ventricle
tricuspid regurgitation
tricuspid valve

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.31083/J.RCM2307220

Cite this

@article{8648230826ef4305bc0e924634c223b3,

title = "Percutaneous Tricuspid Valve Repair",

abstract = "Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternative solution for such patients since they represent a valid alternative to open heart surgery without the significant risks carried by surgery. A number of percutaneous devices are currently under clinical development. This review will discuss about the latest development in the field of percutaneous tricuspid valve repair with possible future developments.",

keywords = "heart failure, percutaneous tricuspid valve repair, right heart failure, right ventricle, tricuspid regurgitation, tricuspid valve",

author = "Antonio Mangieri and Alessandro Sticchi and Aisha Gohar and Damiano Regazzoli and Fabio Fazzari and Daniela Pini and Marta Pellegrino and Beniamino Pagliaro and Ferdinando Loiacono and Mauro Chiarito and Bernhard Reimers and Fabien Praz and Azeem Latib and Antonio Colombo",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by IMR Press. This is an open access article under the CC BY 4.0 license.",

year = "2022",

doi = "10.31083/J.RCM2307220",

language = "English (US)",

volume = "23",

journal = "Reviews in Cardiovascular Medicine",

issn = "1530-6550",

publisher = "MedReviews LLC",

number = "7",

}

TY - JOUR

T1 - Percutaneous Tricuspid Valve Repair

AU - Mangieri, Antonio

AU - Sticchi, Alessandro

AU - Gohar, Aisha

AU - Regazzoli, Damiano

AU - Fazzari, Fabio

AU - Pini, Daniela

AU - Pellegrino, Marta

AU - Pagliaro, Beniamino

AU - Loiacono, Ferdinando

AU - Chiarito, Mauro

AU - Reimers, Bernhard

AU - Praz, Fabien

AU - Latib, Azeem

AU - Colombo, Antonio

PY - 2022

Y1 - 2022

N2 - Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternative solution for such patients since they represent a valid alternative to open heart surgery without the significant risks carried by surgery. A number of percutaneous devices are currently under clinical development. This review will discuss about the latest development in the field of percutaneous tricuspid valve repair with possible future developments.

AB - Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternative solution for such patients since they represent a valid alternative to open heart surgery without the significant risks carried by surgery. A number of percutaneous devices are currently under clinical development. This review will discuss about the latest development in the field of percutaneous tricuspid valve repair with possible future developments.

KW - heart failure

KW - percutaneous tricuspid valve repair

KW - right heart failure

KW - right ventricle

KW - tricuspid regurgitation

KW - tricuspid valve

UR - http://www.scopus.com/inward/record.url?scp=85133975269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133975269&partnerID=8YFLogxK

U2 - 10.31083/J.RCM2307220

DO - 10.31083/J.RCM2307220

M3 - Review article

AN - SCOPUS:85133975269

SN - 1530-6550

VL - 23

JO - Reviews in Cardiovascular Medicine

JF - Reviews in Cardiovascular Medicine

IS - 7

M1 - 220

ER -

Percutaneous Tricuspid Valve Repair

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this